Pfizer, GSK Price-Fixing Suit Won't Get High Court Review
The U.S. Supreme Court declined Monday to review a lower court's dismissal of a consolidated antitrust case alleging that Pfizer Inc., GlaxoSmithKline PLC and other drug companies conspired to inflate U.S....To view the full article, register now.
Already a subscriber? Click here to view full article